Gsk Plc Stock Today
| GLAXF Stock | USD 16.94 0.08 0.47% |
Performance0 of 100
| Odds Of DistressLess than 35
|
GSK Plc is trading at 16.94 as of the 22nd of November 2024. This is a 0.47 percent increase since the beginning of the trading day. The stock's lowest day price was 16.75. GSK Plc has about a 35 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for GSK plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. The company has 4.09 B outstanding shares. More on GSK plc
Moving together with GSK Pink Sheet
| 0.8 | LLY | Eli Lilly | PairCorr |
| 0.83 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.94 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.62 | RHHBY | Roche Holding | PairCorr |
| 0.68 | RHHVF | Roche Holding AG | PairCorr |
Moving against GSK Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GSK Pink Sheet Highlights
| President | Emma Walmsley |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
GSK plc [GLAXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Large-Cap' category with a current market capitalization of 73.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GSK Plc's market, we take the total number of its shares issued and multiply it by GSK Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GSK plc classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 4.09 B outstanding shares.
GSK plc has accumulated about 6.53 B in cash with 7.4 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62.
Check GSK Plc Probability Of Bankruptcy
Ownership AllocationGSK plc has a total of 4.09 Billion outstanding shares. 30% of GSK plc outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GSK Ownership Details
GSK plc Risk Profiles
| Mean Deviation | 2.14 | |||
| Standard Deviation | 3.08 | |||
| Variance | 9.47 | |||
| Risk Adjusted Performance | (0.06) |
GSK Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GSK Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
GSK Plc Corporate Management
| David Redfern | Chief Strategy Officer | Profile | |
| Diana Conrad | Chief Officer | Profile | |
| Sally Jackson | VP Office | Profile | |
| Shobie Ramakrishnan | Chief Officer | Profile |
Other Information on Investing in GSK Pink Sheet
GSK Plc financial ratios help investors to determine whether GSK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.